200 related articles for article (PubMed ID: 34199610)
1. [3 + n] Cycloaddition Reactions: A Milestone Approach for Elaborating Pyridazine of Potential Interest in Medicinal Chemistry and Optoelectronics.
Amariucai-Mantu D; Mangalagiu V; Mangalagiu II
Molecules; 2021 Jun; 26(11):. PubMed ID: 34199610
[TBL] [Abstract][Full Text] [Related]
2. Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review.
Garrido A; Vera G; Delaye PO; Enguehard-Gueiffier C
Eur J Med Chem; 2021 Dec; 226():113867. PubMed ID: 34607244
[TBL] [Abstract][Full Text] [Related]
3. Inverse-Electron-Demand Diels-Alder Reactions for the Synthesis of Pyridazines on DNA.
Li H; Sun Z; Wu W; Wang X; Zhang M; Lu X; Zhong W; Dai D
Org Lett; 2018 Nov; 20(22):7186-7191. PubMed ID: 30365326
[TBL] [Abstract][Full Text] [Related]
4. New pyridazine derivatives: synthesis, chemistry and biological activity.
Butnariu RM; Mangalagiu II
Bioorg Med Chem; 2009 Apr; 17(7):2823-9. PubMed ID: 19272782
[TBL] [Abstract][Full Text] [Related]
5. Bioorthogonal Fluorescence Turn-On Labeling Based on Bicyclononyne-Tetrazine Cycloaddition Reactions that Form Pyridazine Products.
Siegl SJ; Galeta J; Dzijak R; Dračínský M; Vrabel M
Chempluschem; 2019 May; 84(5):493-497. PubMed ID: 31245251
[TBL] [Abstract][Full Text] [Related]
6. [New pyridazine compounds with possible physiological action].
Stefănescu E; Petrovanu M; Caproşu M
Rev Med Chir Soc Med Nat Iasi; 1990; 94(3-4):589-94. PubMed ID: 2131557
[TBL] [Abstract][Full Text] [Related]
7. New pyridazine-fluorine derivatives: synthesis, chemistry and biological activity. Part II.
Tucaliuc RA; Cotea VV; Niculaua M; Tuchilus C; Mantu D; Mangalagiu II
Eur J Med Chem; 2013 Sep; 67():367-72. PubMed ID: 23891981
[TBL] [Abstract][Full Text] [Related]
8. Highly enantioselective dearomatizing formal [3+3] cycloaddition reactions of N-acyliminopyridinium ylides with electrophilic enol carbene intermediates.
Xu X; Zavalij PY; Doyle MP
Angew Chem Int Ed Engl; 2013 Nov; 52(48):12664-8. PubMed ID: 24123489
[TBL] [Abstract][Full Text] [Related]
9. A One-Pot Approach to Novel Pyridazine
Cermola F; Vella S; DellaGreca M; Tuzi A; Iesce MR
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920588
[TBL] [Abstract][Full Text] [Related]
10. Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules.
He ZX; Gong YP; Zhang X; Ma LY; Zhao W
Eur J Med Chem; 2021 Jan; 209():112946. PubMed ID: 33129590
[TBL] [Abstract][Full Text] [Related]
11. Microwave Assisted Reactions of Fluorescent Pyrrolodiazine Building Blocks.
Moldoveanu C; Amariucai-Mantu D; Mangalagiu V; Antoci V; Maftei D; Mangalagiu II; Zbancioc G
Molecules; 2019 Oct; 24(20):. PubMed ID: 31635419
[TBL] [Abstract][Full Text] [Related]
12. [(p-tolyl)-pyridazium-ylides. VI. New pyridazine compounds with possible biological action. Apropos of 3-(p-tolyl)-pyridazine-carbethoxy-methyl-ylide].
Stefănescu E; Petrovanu M
Rev Med Chir Soc Med Nat Iasi; 1977; 81(2):291-4. PubMed ID: 905691
[No Abstract] [Full Text] [Related]
13. Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry.
Bull JA; Croft RA; Davis OA; Doran R; Morgan KF
Chem Rev; 2016 Oct; 116(19):12150-12233. PubMed ID: 27631342
[TBL] [Abstract][Full Text] [Related]
14. Preparation of new [1,2,4]triazolo[4,3-b]pyridazines. Part 12: Studies in the field of pyridazine compounds.
Kosáry J; Kasztreiner E; Lázár A; Sóti M
Pharmazie; 1983 Jun; 38(6):369-71. PubMed ID: 6611639
[TBL] [Abstract][Full Text] [Related]
15. Rigid congeners of arylpyridazinones. IV. Synthesis and activity of derivatives of the new heterocyclic system 9H-indeno[2,1-c]pyridazine.
Pinna GA; Curzu MM; Loriga M; Cignarella G; Barlocco D; Malandrino S
Farmaco Sci; 1985 Dec; 40(12):979-86. PubMed ID: 3879224
[TBL] [Abstract][Full Text] [Related]
16. Bicyclic [b]-heteroannelated pyridazine derivatives. Part 6. Aromatization of some tetrahydrotriazolo[4,3-b]pyridazine derivatives with potential activity as benzodiazepine receptor ligands.
Lange J; Karolak-Wojciechowska J; Gniewosz M; Kuliński T; Plenkiewicz J
Acta Pol Pharm; 1997; 54(4):299-305. PubMed ID: 9511458
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives.
Popovici L; Amarandi RM; Mangalagiu II; Mangalagiu V; Danac R
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):230-243. PubMed ID: 30734610
[TBL] [Abstract][Full Text] [Related]
18. Use of 4-bromo pyridazine 3,6-dione for building 3-amino pyridazine libraries.
Schmitt M; de Araújo-Júnior JX; Oumouch S; Bourguignon JJ
Mol Divers; 2006 Aug; 10(3):429-34. PubMed ID: 16896543
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer.
Bradbury RH; Hales NJ; Rabow AA; Walker GE; Acton DG; Andrews DM; Ballard P; Brooks NA; Colclough N; Girdwood A; Hancox UJ; Jones O; Jude D; Loddick SA; Mortlock AA
Bioorg Med Chem Lett; 2011 Sep; 21(18):5442-5. PubMed ID: 21782422
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis and antidepressive effects of diaryl-4,6-amino-3-pyridazine analogs of minaprine].
Coudert P; Rubat C; Couquelet JM; Bastide J
Farmaco Sci; 1988 Oct; 43(10):793-800. PubMed ID: 3240830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
